Effect of genetically caused excess of brain gamma-hydroxybutyric acid and GABA on sleep

Sleep

Volumn 28, Issue 4, 2005, Pages 418-424

  Arnulf, Isabelle ^a,e   Konofal, Eric ^a   Gibson, K Michael ^b   Rabier, Daniel ^c   Beauvais, Pierre ^d   Derenne, Jean Philippe ^a   Philippe, Anne ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d ARMAND TROUSSEAU HOSPITAL   (France)

^e Stanford California and Cofounder   (United States)

Author keywords

GABA; Gamma hydroxybutyrate; GHB; Slow wave sleep; SSADH

Indexed keywords

4 AMINOBUTYRIC ACID; 4 HYDROXYBUTYRIC ACID; SUCCINATE SEMIALDEHYDE DEHYDROGENASE;

ADOLESCENT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; HUMAN; HUMAN TISSUE; INTERVIEW; LYMPHOCYTE; METABOLIC DISORDER; NARCOLEPSY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SEIZURE; SLEEP DISORDER; SLEEP TIME; SLEEP WAKING CYCLE; SLOW BRAIN WAVE; URINE LEVEL;

EID: 16844374927     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/28.4.418     Document Type: Article

References (39)

1. Gibson KM, Hoffmann GF, Hodson AK, Bottiglieri T, Jakobs C. 4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism. Neuropediatrics 1998;29(1):14-22.
2. Ethofer T, Seeger U, Klose U, Erb M, Kardatzki B, Kraft E, et al. Proton MR spectroscopy in succinic semialdehyde dehydrogenase deficiency. Neurology 2004;62(6):1016-8.
3. Pearl PL, Gibson KM, Acosta MT, Vezina LG, Theodore WH, Rogawski MA, et al. Clinical spectrum of succinic semialdehyde dehydrogenase deficiency. Neurology 2003;60(9):1413-7.
4. Bessman SP, Fishbein WN. Gamma-Hydroxybutyrate, a Normal Brain Metabolite. Nature 1963;200:1207-8.
5. Wong CG, Gibson KM, Snead OC, 3rd. From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends Pharmacol Sci 2004;25(1):29-34.
6. Maitre M. The gamma-hydroxybutyrate signalling system in brain: organisation and functional implications. Progr Neurobiol 1997;51:337-61.
7. Laborit H, Larcan A, Kind A. Le gamma-hydroxybutyrate en anesthésie neurochirurgicale. Neurochirugie 1962;8:10-4.
8. Broughton R, Mamelak M. Effects of nocturnal gamma-hydroxybutyrate on sleep/waking patterns in narcolepsy-cataplexy. Can J Neurol Sci 1980;7(1):23-31.
9. US Xyrem® Multicenter Study Group. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy. Sleep 2003;26(1):31-5.
10. Chin RL, Sporer KA, Cullison B, Dyer JE, Wu TD. Clinical course of gamma-hydroxybutyrate overdose. Ann Emerg Med 1998;31(6):716-22.
11. Varela M, Nogue S, Oros M, Miro O. Gamma hydroxybutirate use for sexual assault. Emerg Med J 2004;21(2):255-6.
12. Roth RH, Doherty JD, Walters JR. Gamma-hydroxybutyrate: a role in the regulation of central dopaminergic neurons? Brain Res 1980;189(2):556-60.
13. Nava F, Carta G, Bortolato M, Gessa GL. gamma-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABA(B) receptors. Eur J Pharmacol 2001;430(2-3):261-3.
14. Gobaille S, Schleef C, Hechler V, Viry S, Aunis D, Maitre M. Gamma-hydroxybutyrate increases tryptophan availability and potentiates serotonin turnover in rat brain. Life Sci 2002;70(18):2101-12.
15. Mamelak M, Black JE, Montplaisir J, Ristanovic R. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep 2004;27(7):1327-34.
16. Gibson KM, Christensen E, Jakobs C, Fowler B, Clarke MA, Hammersen G, et al. The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients. Pediatrics 1997;99(4):567-74.
17. Gibson KM, Gupta M, Pearl PL, Tuchman M, Vezina LG, Snead OC, 3rd, et al. Significant behavioral disturbances in succinic semi-aldehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria). Biol Psychiatry 2003;54(7):763-8.
18. Philippe A, Deron J, Genevieve D, de Lonlay P, Gibson KM, Rabier D, et al. Neurodevelopmental pattern of succinic semialdehyde dehydrogenase deficiency (gamma-hydroxybutyric aciduria). Dev Med Child Neurol 2004;46(8):564-8.
19. Rahbeeni Z, Ozand PT, Rashed M, Gascon GG, al Nasser M, al Odaib A, et al. 4-Hydroxybutyric aciduria. Brain Dev 1994;16 Suppl:64-71.
20. Johns MH. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-5.
21. Carskadon MA, Mitler MM, Roth T. Guidelines for the Multiple Sleep Latency Test (MSLT): a standard measure of sleepiness. Sleep 1986;9:519-24.
22. Rechstchaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute., 1968.
23. American Sleep Disorders Association. EEG arousals: Scoring rules and examples. A preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:174-84.
24. American Academy of Sleep Medicine Task Force. Sleep-disordered breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22(5):667-88.
25. American Sleep Disorders Association Atlas Task Force. Recording and scoring leg movements. Sleep 1993;16:749-59.
26. McCormick L, Nielsen T, Nicolas A, Ptito M, Montplaisir J. Topographical distribution of spindles and K-complexes in normal subjects. Sleep 1997;20:939-41.
27. Williams R, Karacan I, Hursch C. Electroencephalography of human sleep: clinical applications. New York: John Wiley & Sons, 1974.
28. Gupta M, Hogema BM, Grompe M, Bottiglieri TG, Concas A, Biggio G, et al. Murine succinate semialdehyde dehydrogenase deficiency. Ann Neurol 2003;54 Suppl 6:881-90.
29. Williams SR, Turner JP, Crunelli V. Gamma-hydroxybutyrate promotes oscillatory activity of rat and cat thalamocortical neurons by a tonic GABAB, receptor-mediated hyperpolarization. Neuroscience 1995;66(1):133-41.
30. Pearl PL, Novotny EJ, Acosta MT, Jakobs C, Gibson KM. Succinic semialdehyde dehydrogenase deficiency in children and adults. Ann Neurol 2003;54 Suppl 6:873-80.
31. Mamelak M, Escriu JM, Stokan O. The effects of gamma-hydroxybutyrate on sleep. Biol Psychiatry 1977;12(2):273-88.
32. Lapierre O, Montplaisir J, Lamarre M, Bedard MA. The effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: further considerations on REM sleep-triggering mechanisms. Sleep 1990;13(1):24-30.
33. Pearl PL, Gibson KM. Clinical aspects of the disorders of GABA metabolism in children. Curr Opin Neurol 2004;17(2):107-13.
34. Hogema B, Gupta M, Senephansiri H, et al. Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase. Nat Genet 2001;29:212-6.
35. Bazil C, Castro L, Walczak T. Reduction of rapid eye movement sleep by diurnal and nocturnal seizures in temporal lobe epilepsy. Arch Neurol. 2000;57:363-8.
36. Deluca A, Pivik R, Chorover S. Electroconvulsive shok: effects on sleep and cortical steady potential in the rat. Physiol Behav 1977;18:997-1003.
37. Thomas PM, Phillips JP, Delanty N, O'Connor WT. Elevated extracellular levels of glutamate, aspartate and gamma-aminobutyric acid within the intraoperative, spontaneously epileptiform human hippocampus. Epilepsy Res 2003;54(1):73-9.
38. Jacobsen RB, Ulrich D, Huguenard JR. GABA(B) and NMDA receptors contribute to spindle-like oscillations in rat thalamus in vitro. J Neurophysiol 2001;86(3):1365-75.
39. Brankack J, Lahtinen H, Koivisto E, Riekkinen PJ. Epileptogenic spikes and seizures but not high voltage spindles are induced by local frontal cortical application of gamma-hydroxybutyrate. Epilepsy Res 1993;15(2):91-9